Role of TGF-β1 variation in type 1 diabetes and cardiovascular complications

Document Type : Letter to Editor

Author

Zohreh Jadali

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Keywords

Atherosclerosis

Inflammation

Cytokine

Immune System

Pathogenesis

Tjahjono HA, Barlianto W, Handayani D, Kalim H. Correlation between transforming growth factor-β1 (TGF- β1) with premature atherosclerosis in type 1 diabetes. ARYA Atheroscler. 2024;20(4):7-13. https://doi.org/10.48305/arya.2024.11581.2125
Rochmah N, Triastuti IW, Deakandi WY, Irawan R, Faizi M, Endaryanto A. Decreased serum transforming growth factor-beta levels in Indonesian children with type 1 diabetes. J Med Pharm Chem Res 2024; 6(9):1478-84. https://doi.org/10.48309/ecc.2024.434749.1746
Chen PY, Qin L, Simons M. TGFβ signaling pathways in human health and disease. Front Mol Biosci. 2023 Jun 1;10:1113061. https://doi.org/10.3389/fmolb.2023.1113061
He C, Kim HI, Park J, Guo J, Huang W. The role of immune cells in different stages of atherosclerosis. Int J Med Sci. 2024 Apr 22;21(6):1129-43. https://doi.org/10.7150/ijms.94570
Liuizė Abramavičiūtė A, Mongirdienė A. TGF-β Isoforms and GDF-15 in the Development and Progression of Atherosclerosis. Int J Mol Sci. 2024 Feb 9;25(4):2104. https://doi.org/10.3390/ijms25042104
Chen PY, Qin L, Li G, Wang Z, Dahlman JE, Malagon-Lopez J, et al. Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis. Nat Metab. 2019 Sep;1(9):912-26. https://doi.org/10.1038/s42255-019-0102-3

Article View	702
PDF Download	139

ARYA Atherosclerosis Journal